/

Sociétés

Hi

Non vérifié

Hims & Hers

Ce que nous écrivons

Fitness/Bien-êtreIndustrie pharmaceutiqueSantéSanté PubliqueVitrines/Shopping

68 communiqués de presse

Voir tous les communiqués de presse

04/06/2026

Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims

Source

Émetteur

1.00

0

02/06/2026

Hims & Hers Completes Acquisition of Eucalyptus, Advancing Position as the World's Largest Consumer Health Platform

Source

Émetteur

1.00

0

02/06/2026

Hims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for Canadians

Source

Émetteur

1.00

0

02/06/2026

Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World’s Largest Consumer Health Platform

Source

Émetteur

1.00

0

02/06/2026

Hims & Hers Completes Acquisition of Eucalyptus, Expanding Access to Comprehensive, Clinically-Backed Weight Management Care in Germany

Source

Émetteur

1.00

0

02/06/2026

Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market

Source

Émetteur

1.00

0

28/05/2026

Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners

Source

Émetteur

1.00

0

21/05/2026

Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide

Source

Émetteur

1.00

0

21/05/2026

Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada

Source

Émetteur

1.00

0

19/05/2026

Technique

Technologies Diverses

Logiciels

Santé Publique

Industrie pharmaceutique

Santé

Technologies de l'Information

Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment

Source

Émetteur

1.00

0

Followers

0

Compatibilité

0